Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Psychiatry, 10 December 2025

Sec. Psychopharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fpsyt.2025.1754488

Correction: OXTR rs2254298 polymorphism influences escitalopram response in Generalized Anxiety Disorder: a sex-specific role for oxytocin signaling

This article is a correction to:

  1. OXTR rs2254298 polymorphism influences escitalopram response in Generalized Anxiety Disorder: a sex-specific role for oxytocin signaling

    1. Read original article
Liang Xue*Liang Xue1*Hongfen NiHongfen Ni2Hong DaiHong Dai1
  • 1Department of Psychiatry, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou, China
  • 2Department of Laboratory Medicine, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou, China

A Correction on
OXTR rs2254298 polymorphism influences escitalopram response in Generalized Anxiety Disorder: a sex-specific role for oxytocin signaling

By Xue L, Ni H and Dai H (2025) Front. Psychiatry 16:1718106. doi: 10.3389/fpsyt.2025.1718106

The author affiliations in the published paper were erroneously given as:

“Liang Xue1,2, Hongfen Ni2,3, Hong Dai1,2

1Department of Psychiatry, Huzhou Third Municipal Hospital, Huzhou, China

2The Affiliated Hospital of Huzhou Normal College, Huzhou, China

3Department of Laboratory Medicine, Huzhou Third Municipal Hospital, Huzhou, China”

The correct author list and affiliations read:

“Liang Xue1*, Hongfen Ni2, Hong Dai1

1Department of Psychiatry, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou, China

2Department of Laboratory Medicine, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou, China”

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Generalized Anxiety Disorder, oxytocin, OXTR gene, pharmacogenetics, sex differences, treatment response, SSRI

Citation: Xue L, Ni H and Dai H (2025) Correction: OXTR rs2254298 polymorphism influences escitalopram response in Generalized Anxiety Disorder: a sex-specific role for oxytocin signaling. Front. Psychiatry 16:1754488. doi: 10.3389/fpsyt.2025.1754488

Received: 26 November 2025; Accepted: 27 November 2025;
Published: 10 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Xue, Ni and Dai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Liang Xue , eGwwMjA4NzMzNDA2N0AxMjYuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.